Her research interests center on translational research in pharmacogenomics for personalization of pediatric analgesia. Dr.Chidambaran received the Translational Scholar Career Award in Pharmacogenomics and Personalized Medicine (NICHD) to identify and characterize genetic and phenotypic predictors of morphine induced respiratory depression in postsurgical children, as well as to study gene-gene and gene-environmental interactions affecting morphine pharmacokinetics and pharmacodynamics. She was awarded the Young Investigator Award – 1st place by the Society of Pediatric Anesthesia for two consecutive years (2010 and 2011) for her findings on ABCB1 effects on morphine induced respiratory depression and PK/PD optimization of propofol dosing in morbidly obese adolescents. She received an Outstanding Research Award (2016) from the Society of Pediatric Pain Medicine for her presentation on FAAH variant effects on morphine induced depression of hypercarbic ventilatory response in adolescents after spinal fusion. Her honors include competitive institutional grants including a “Center of Pediatric Genomics” award, and being the first pediatric anesthesiologist to receive the Safety Scientist Career Development Award from the Anesthesia Patient Safety Foundation.